• Commercial strategy that accelerates and sustains pharma sales

  • Accelerate your product with the largest commercial footprint in the industry – a global pharma sales infrastructure to fuel your success.

    • Increase market penetration and sales
    • Lower risk and maximize value during product commercialization
    • Reveal your product's value to regulators, payers, providers and patients
    • Make “go/no go” decisions through the entire product lifecycle

  • Our Perspectives 

    slider image

    Delivering Value to Market

    This paper examines the various options available to biotech companies as they look to commercialize their innovative products. Read whitepaper

    slider image

    Stakeholder Value: Overcoming Complexity in the European Market

    This paper advocates early planning to ensure the right data is gathered in clinical trials including real-world data collection. Read whitepaper

    slider image

    Allume Launch Planning Solution

    Allume™, provides the expertise, and real-world experience and access to the localized resources you need to achieve commercial success. Read brochure

    slider image

    Outsourcing in a Changing Environment

    Head of US Commercial operations at Quintiles, Daryl Gaugler, presented ways to build strategic value by going beyond tactical commercial outsourcing. Review presentation

    slider image

    A Blueprint for Clinical / Commercial Convergence

    Bio pharmaceutical companies must shift from two divergent paths to one that combines clinical and commercial resources. Read white paper

  •  
     

    Video Spotlights 

  • Differentiate your product from the start to build sustainable markets

    Quintiles
    Unlike a traditional pharma CSO, Quintiles integrates clinical and commercial strategy to prove unique value.

    Balance your resourcing as your portfolio adjusts to pipeline, regulatory and market fluctuations.     Learn how

    Identify outcome and pricing requirements to demonstrate value to diverse stakeholders. Read more

    Multi-channel solutions offer new opportunities to use resources more cost-effectively. Find out how

  • Featured News

    Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research
    Read more

    Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock
    Read more

    Quintiles Announces Pricing of Initial Public Offering
    Read more

    Our Perspectives

    Harnessing the Power of the Digital Patient White Paper
    Read more

    Tomorrow’s Path to Improved Early-Phase Oncology Drug Development
    Read more

    Strategic Portfolio Management & New Influencers in R&D Decision-Making
    Read more